ABCC5 and posterior cortical atrophy: To assess the resensitization of PCa cells to enzalutamide by targeting ABCC5 in vivo, xenografted 22RV1Enza cells were subjected to the combination treatment (ABCC5 knockdown and enzalutamide treatment) in nude mouse that were surgically castrated one week before injection (Fig. 4D).